309 related articles for article (PubMed ID: 18722291)
1. Intraoperative radiation therapy after radical prostatectomy: in regard to Saracino et Al. (Int j radiat oncol biol phys, in press).
Jereczek-Fossa BA; Orecchia R
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):305-6; author reply 306. PubMed ID: 18722291
[No Abstract] [Full Text] [Related]
2. In regard to Cozzarini et al.: Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single-institute experience of 415 patients (Int J Radiat Oncol Biol Phys 2004;59:674-683).
Magrini SM; Caraffini B; Bertoni F
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1660; author reply 1660-1. PubMed ID: 15590200
[No Abstract] [Full Text] [Related]
3. Response to "Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer: technical and dosimetric aspects" (Int J Radiat Oncol Biol Phys 2009; in press).
Thoms J; Bristow R; Warde P; Supiot S
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1277; author reply 1277. PubMed ID: 20206029
[No Abstract] [Full Text] [Related]
4. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
Schulz RJ; Kagan AR
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
[No Abstract] [Full Text] [Related]
5. Commentary on dose escalation and biochemical failure in prostate cancer: in regard to Eade et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
Schulz RJ; Kagan AR
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207038
[No Abstract] [Full Text] [Related]
6. Radiation dose is predictive of biochemical failure, local failure, and distant metastases. In regard to Kupelian et Al. (Int J Radiat Oncol Biol Phys 2008;71:16-22).
Kelly P
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1621-2; author reply 1622. PubMed ID: 19028291
[No Abstract] [Full Text] [Related]
7. Androgen Deprivation (AD) among low-risk and intermediate-risk prostate cancer patients: in regard to Ciezki et al. (Int J Radiat Oncol Biol Phys 2004;60:1347-1350).
Oton CA
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):291-2; author reply 292. PubMed ID: 15850937
[No Abstract] [Full Text] [Related]
8. Rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer (Int J Radiat Oncol Biol Phys 2010;76:342-348).
Hyde C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1607; author reply 1607. PubMed ID: 20637987
[No Abstract] [Full Text] [Related]
9. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. In regard to Bhojani et al. (Int J Radiat Oncol Biol Phys 2010;76:342-348.).
Weber DC; Combescure C
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):314-5; author reply 315. PubMed ID: 20708488
[No Abstract] [Full Text] [Related]
10. Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348).
Froehner M; Wirth MP
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1279; author reply 1280. PubMed ID: 20542389
[No Abstract] [Full Text] [Related]
11. In regard to Kupelian et al.: Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1-T2 prostate cancer (Int J Radiat Oncol Biol Phys 2004;58:25-33).
Halperin RM
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):631-2; author reply 632. PubMed ID: 15667989
[No Abstract] [Full Text] [Related]
12. Response to "Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy" (Int J Radiat Oncol Biol Phys 2009, in press).
Froehner M; Koch R; Litz RJ; Wirth MP
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1274. PubMed ID: 20206022
[No Abstract] [Full Text] [Related]
13. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
Yaeger TE
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
[No Abstract] [Full Text] [Related]
14. Clinical target volume for rectal cancer: in regard to Roels et al. (Int J Radiat Oncol Biol Phys 2006;65:1129-1142).
Bujko K; Bujko M; Pietrzak L
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):313. PubMed ID: 17448884
[No Abstract] [Full Text] [Related]
15. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: in regard to Kwan et al. (Int J Radiat Oncol Biol Phys 2004;60:1040-1046).
Williams S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253-4; author reply 1254. PubMed ID: 15990030
[No Abstract] [Full Text] [Related]
16. CTV margins in prostate cancer irradiation. In regard to Teh et al.: IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease (Int J Radiat Oncol Biol Phys 2003;56:184-191).
Macias V
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):320-1; author reply 321-2. PubMed ID: 15093933
[No Abstract] [Full Text] [Related]
17. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
Cheung MR
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
[No Abstract] [Full Text] [Related]
18. Breast conservative surgery with close or positive margins: in regard to Guinot et Al. (Int J Radiat Oncol Biol Phys 2007;68:1381-1387).
Sanz J; de Dios NR; Arnalot PF; López MA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):962-3; author reply 963. PubMed ID: 18262110
[No Abstract] [Full Text] [Related]
19. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
[No Abstract] [Full Text] [Related]
20. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
Russi EG; Pergolizzi S; Lucio F; Ricardi U
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
